standard-title
Oxcarbazepine Tablets IP 150mg Manufacturers & Suppliers in India Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Oxcarbazepine Tablets IP 150mg; at Taj Pharma we will appropriately meet diverse needs for Oxcarbazepine Tablets IP 150mg export manufacturing in a wide range of activities from investigation of possible formulations of Oxcarbazepine Tablets IP 150mg, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Oxcarbazepine Tablets IP 150mg through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. As Oxcarbazepine Tablets IP 150mg Exporters, we can cater business queries from the following geographies: Turkey, Cyprus, Guatemala, El Salvador, Cayman Island, Jamaica, Mozambique, Ecuador, Colombia, Malawi, St Lucia, Papua New Guinea, Gambia, Venezuela, Trinidad & Tobago, Somalia, Guyana, Libya, Seychelles, All West Indies Country, Sierra Leone.
Oxcarbazepine Tablets IP 150mg Manufacturers & Suppliers in India
Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Oxcarbazepine Tablets IP 150mg; at Taj Pharma we will appropriately meet diverse needs for Oxcarbazepine Tablets IP 150mg export manufacturing in a wide range of activities from investigation of possible formulations of Oxcarbazepine Tablets IP 150mg, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Oxcarbazepine Tablets IP 150mg through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. As Oxcarbazepine Tablets IP 150mg Exporters, we can cater business queries from the following geographies: Turkey, Cyprus, Guatemala, El Salvador, Cayman Island, Jamaica, Mozambique, Ecuador, Colombia, Malawi, St Lucia, Papua New Guinea, Gambia, Venezuela, Trinidad & Tobago, Somalia, Guyana, Libya, Seychelles, All West Indies Country, Sierra Leone.
GENERIC NAME OF THE MEDICINAL PRODUCT:
Oxcarbazepine Extended Release Tablets IP 150mg Taj Pharma Oxcarbazepine Extended Release Tablets IP 300mg Taj Pharma Oxcarbazepine Extended Release Tablets IP 600mg Taj Pharma Oxcarbazepine Sustained Release Tablets IP 300mg Taj Pharma Oxcarbazepine Sustained Release Tablets IP 450mg Taj Pharma Oxcarbazepine Sustained Release Tablets IP 600mg Taj Pharma Oxcarbazepine Tablets IP 150mg Taj Pharma Oxcarbazepine Tablets IP 300mg Taj Pharma Oxcarbazepine Tablets IP 450mg Taj Pharma Oxcarbazepine Tablets IP 600mg Taj Pharma
Contract Manufacturing
Taj Pharmaceuticals is an ISO 9001:2015, WHO:GMP, GLP Certified Pharmaceuticals Company in Mumbai and Gujarat offering more than 1500+ high quality Medical Products. Taj Pharmaceuticals has its own manufacturing unit with sections like Injectable, Tablets, Capsules, Soft Gelatin Capsules, Oral Liquid (Syrup & Suspension), Oral Dry Syrup, External Liquids, Ointments, Creams, Betalactum Products, General Products , Nutraceuticals, Soaps, Shampoo, Eye Drops, Ear Drops , Oral Sachets & Powders , External Powder & Cosmetics. Taj Pharmaceutical has 1500+ product approvals of which many are latest molecules launched in industry. Taj Pharma India caters to all segments like Gynaecology, Dermatology, Ophthalmic, Critical Care, Paediatric, Orthopaedic, Ayurvedic, Nutraceuticals, Cosmetics, Oncology, Cardiac-Diabetic & many more. Third Party Manufacturing & Contract Manufacturing also available.
Manufacturing Unit
Built up area of approx. 100,000 sq. ft with separate areas for production, stores & non process blocks.
Engineering, Utilities to commensurate production facility
Designed and built as per vertical flow concept of man – material movement
Highly skilled and experienced technical staff
Immaculate environmental monitoring, calibration and validation programme
c-GMP compliant with latest manufacturing equipments
Dedicated & modular laboratories with latest sophisticated instruments as per GLP norms
Automated access control system and fully equipped cameras
Separate entry and exit for man, material and service personnel for both process blocks
In house water & sewerage treatment plant.
Online Order Tracking
In order to solve the major problem faced by many pharmaceuticals clients is they are always in a state of dilemma that when their product will be dispatched. They are not able to track the lifecycle of product in a transparent manner which causes loss of trust and commitment. Taj Pharmaceuticals has developed a fully automatic online solution which helps you to immediately determine the production stage of products at any given time. Here are the few stages which you can see:
Design Approved
Carton/ Foil Received
Raw Material Ok & Batch Planned
Batch Processed
Testing Done
Packing Done
Dispatched from Plant
Tracking No.
100% Transparent Process
In order to give you full confidence over the quality of product we provide you with many resources such as:
COA (Certificate of Analysis)
Raw Material Procurement Certificate
Batch Inspection Report
Detailed Test Report across 25+ different parameters
With the sufficient proofs in your hand it becomes easy to convince others about the quality of your products.
New Market Opportunities
We want that our customers should always stay ahead of the competition in market. So in order to make it sure, we provide our customers with valuable market intelligence based on our 30+ years of experience in pharma industry.
Timely updates about new product launches.
Competitor Analysis
Correct MRP Guidance
Promotional Material with training
WHO:GMP Certified
At Taj Pharmaceuticals, we use state-of-the-art technology, the most stringent operating procedures and we have earned a name for ourselves for maintaining the highest standards of quality. Taj Pharma India is proud to have received the WHO:GMP certification from Food and Drugs Control Department, Daman and Gujarat.
Taj Pharmaceuticals provide Medicines of good quality at competitive price from good Manufacturers. Domestic and Export both.
It’s great pleasure to introducing ourselves as one of the leading pharmaceutical company based in Mumbai, Maharashtra and Gujarat, India. Taj Pharmaceuticals Contract Manufacturing Division is marketing partner of some WHO, GMP, GLP, ISO9001-2008 certified manufacturers.
Taj Pharmaceuticals is a leading pharmaceutical Company. We are specialized in providing quality products include complete range of all medicine (Human and Vet) which includes,
Tabs
Dry syrups
Capsules
Dry injections
Liquid Injections
Soft gelatin
Penecilline group
Cefalosporin group
Liquid
Sachets
Ointment/Creams
Neutra products etc.
Some of the salient features of our products are:-
Accurate composition
Effective
Pure
Long shelf life
Our Infrastructure Taj Pharmaceuticals’s manufacturing partners having state-of-the-art infrastructure ensures that all our products are of high quality and adhere to international standards. We have a well-equipped production unit that allows us to meet the ever growing demands of the industry. Taj Pharmaceuticals manufacturing facilities are well-maintained to ensure efficient utilization of resources. Our manufacturing partners have a technologically advanced range of equipment and machinery to facilitate high levels of production.
Our Team Taj Pharmaceuticals have developed a team of experienced professionals that form the backbone of Taj Pharmaceuticals Manufacturing partners, Their dedication and hard work has allowed us to attain a position of respect and repute in the industry. Owing to their efforts and creative approach, we have continuously progressed towards expansion of our business. Their in-depth knowledge and expertise coupled with invaluable guidance of our mentor, ensures competent and efficient execution of our methodologies.
Quality Assurance Taj Pharmaceuticals and its Manufacturing partners aim to become a leading player in global market. To succeed in this endeavour, Taj Pharmaceuticals Manufacturing partners have a nurtured a team of dedicated quality analysts who conduct periodic tests on all production stages from procurement of raw materials till the formulation of final product. Taj Pharma ensure that our unit is hygienically maintained and development & packaging of our products is done under hygienic environment. The parameters on which our products are quality tested are:-
Safety
Composition
Shelf Life
Our Strengths Taj Pharmaceuticals and its Manufacturing partners follows business ethics, zero-tolerance quality policy and a highly qualified team are our strengths. We strive to maintain long lasting relationship with our clients by meeting their requirements effectively and efficiently. The numerous factors contributing to our success are:-
Experienced & Skilled Team
stringent quality checks
Proper infrastructure and machinery
Prompt delivery
Competitive Prices
Wide clientele
Taj Pharmaceuticals is a one stop solution for Export/Domestic 3rd party for all Pharmaceutical Formulations.
Taj Pharmaceuticals is looking forward for your co-operation towards development of concrete business and Hoping for a strong and good business relationship in future.
To know more please do visit our website www.tajpharma.in
Want to get your products Manufactured by Taj Pharma?
We at Taj Pharmaceuticals would be happy to help you. Just send your details below and we will take care of everything. (Please don’t post job queries here)
Taj Pharma As A Health Care Provider We put the customer at the front of every decision we make.
Taj Pharma India’s business can be contacted by common group e-mail: tajgroup@tajpharma.com, and query — will be forwarded to the relevant departments; additionally, telephone lines, ” Please Call TAJ PHARMA’s 24X7 helpline number i.e. 1800 222 434 (toll-free), 1800 222 825 (toll-free) Toll free numbers are accessible from all landlines and mobile phones in the country.” can be utilised if -you have an enquiry about the company, our healthcare business, or one of our medicines at India Standard Time (IST).
Taj Pharmaceuticals, one of the leading COVID -19 medicines Manufacturers India brings the best-quality products. The company carries the rich experience in the niche. Taj Pharmaceuticals is reputed manufacturer and COVID -19 medicines suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known COVID -19 medicines Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard. As COVID -19 medicines Exporters
Cancer cure: (Taj Pharma) makes breakthrough in curing the disease with a fast, affordable type of therapy Cancer is a disease that has been around since ancient Egyptian times, and throughout the years, many doctors and scientists alike have been looking and developing a cure. But there is a possibility that the definite cure for cancer has already been made, as India [Taj Pharmaceuticals] makes a breakthrough with their kind of cancer therapy. Cancer cure Bloomberg reports that the new kind of therapy in question was referred to as Chimeric Antigen Receptor-T cells or CAR-T. This process involves drawing blood from the cancer patient to extract the white blood cells or the cells known to fight diseases also known as T-cells. The white blood cells are then engineered in a laboratory, introducing chimeric antigen receptors into the mix. These receptors would then be able to identify and destroy cancer cells, which would then be reintroduced into the body. This incredible breakthrough in cancer treatment was developed by Indian company Taj Pharmaceuticals Ltd, its scientists being a group of renowned Indian cell-therapy researchers. What makes this such a breakthrough is that compared to the usual weeks’ long procedures of many cancer therapies […]
The NHS has embarked on an urgent mission to administer booster shots of Covid and flu vaccines to older residents in care homes across England. This accelerated rollout, set to commence on Monday, aims to swiftly bolster the immunity of those who are at the highest risk due to the emergence of a highly-mutated new Covid variant known as BA.2.86. The BA.2.86 Variant Emergence As of now, there have been 34 confirmed cases of the BA.2.86 variant in England, with a concerning outbreak reported in a care home in Norfolk, accounting for 28 of these cases. Although it’s too early to determine the severity of this new variant compared to its predecessors, the rapid spread has raised alarm bells within the medical community. Prioritizing High-Risk Groups The rollout will initially target adult care homes and housebound individuals, gradually expanding to encompass other eligible groups. Scotland, Wales, and Northern Ireland have also expedited their booster vaccination schedules, beginning in early September. Eligibility for Covid Booster People eligible for the Covid booster include: Residents in care homes for older adults. All adults aged 65 years and over. Individuals aged six months to 64 years in clinical risk groups. Frontline health and social […]
Unraveling Excellence in Iron Chelation Taj Pharmaceuticals stands tall as a distinguished Deferasirox Dispersible Tablets 500mg manufacturer in India. Let’s delve into the intricacies of this remarkable medication and why Taj Pharma is a name synonymous with quality and reliability. Treatment of Chronic Iron Overload – Deferasirox Tablets I. Understanding Deferasirox Dispersible Tablets 500mg A. Introduction to Deferasirox Championing the fight against iron overload, Deferasirox is a potent iron-chelating agent crucial for patients undergoing multiple blood transfusions. B. Therapeutic Indications Unveiling the medical tapestry, Deferasirox addresses ongoing high iron levels post-blood transfusions and offers a lifeline to those with non-transfusion-dependent thalassemia. II. Taj Pharmaceuticals: Pioneering Excellence A. The Taj Pharma Advantage Exploring the facets that make Taj Pharmaceuticals a frontrunner in Deferasirox Dispersible Tablets 500mg manufacturing. B. Quality Control Measures A deep dive into Taj Pharma’s stringent quality control, ensuring each tablet maintains an unwavering standard of excellence. III. Deferasirox Dispersible Tablets: Variants and Composition A. Generic Names and Composition Breaking down the different variants, from 100mg to 500mg, and their qualitative compositions. B. Qualitative and Quantitative Composition Understanding the meticulous composition details, emphasizing the commitment to consistency. IV. Caution, Schedule, and Proper Usage A. Cautionary Measures Guiding users on […]
Full disclosure, I spend about 73% of my time obsessing about whether there will be summer camp in Rhode Island. I send borderline appropriate emails to people I work with on virus response, nagging them about this. CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
When the sniffles strike and your nose won’t stop running, it’s time to reach for a reliable cold medicine kit. Taj Pharmaceuticals Limited, a renowned pharmaceutical company headquartered in Mumbai, India, offers a comprehensive solution for those battling a runny nose due to cold or allergies. In this article, we will explore the Taj Pharmaceuticals Runny Nose Cold Medicine Kit, consisting of four essential tablets designed to provide you with relief and comfort during the trying times of a cold. Understanding Taj Pharmaceuticals Limited Before delving into the specifics of the cold medicine kit, let’s get to know Taj Pharmaceuticals Limited a little better. Taj Pharmaceuticals is a prominent player in the pharmaceutical industry, manufacturing and distributing a wide range of medicines. Their product portfolio encompasses prescription solutions, life-saving drugs, anti-cancer medications, veterinary products, consumer brands, and CNS drugs. With a strong focus on various medical conditions such as anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases, Taj Pharmaceuticals stands as a reliable name in healthcare. Global Leader in Generics Taj Pharmaceuticals Limited has earned its reputation as a global leader in generics and ranks among […]
Covid-19’s duration varies widely depending on severity, but now we know the rough range. In the early weeks of the Covid-19 crisis, little was known about the wide range of possible symptoms and the typical progression of the disease. Now, more than three months into the coronavirus outbreaks, doctors and researchers are finally getting a handle on the typical duration of the illness and how it plays out.
Taj Pharmaceuticals Limited: Pioneering Excellence in Betalactam Dry Powder Injectable Manufacturing Unveiling Taj Pharmaceuticals Limited’s State-of-the-Art Facility In the realm of pharmaceuticals, Taj Pharmaceuticals Limited stands tall as a leading manufacturer and exporter of Betalactam Dry Powder Injectable. With its cutting-edge manufacturing facility nestled in India, the company has etched its name in the global pharmaceutical landscape. PICs WHO-GMP Accredited Company Our State-of-the-Art Manufacturing Facility Compliance with the Newest Norms At Taj Pharmaceuticals Limited, our manufacturing facility is a testament to innovation and adherence to the latest norms. We take pride in constructing a facility that aligns with the most recent industry standards, ensuring the production of pharmaceuticals that meet and exceed global benchmarks. International Regulatory Approvals Our commitment to quality is reflected in the approval of our facility by several international drug regulatory authorities, including the Philippines. We operate under the stringent guidelines of WHO cGMP and PIC/s norms, assuring the highest quality standards in the production of Betalactam Dry Powder Injectable. Exploring the Product Portfolio: A Gateway to Mutual Business Growth Ceftriaxone Sodium Injection 1000mg/500mg/250mg/2000mg/3000mg variants catering to diverse medical needs. Ceftriaxone Sodium + Sulbactam Sodium Inj. 1500mg/750mg/375mg/4500mg formulations, blending efficacy with versatility. Ceftriaxone Sodium + Tazobactam Sodium […]
What You Should Know US authorities have given the green light to a new COVID-19 booster shot designed to combat one of the most prevalent strains of the virus currently in circulation. As we approach the cold and flu season, the Food and Drug Administration (FDA) has granted emergency use authorization for updated single-dose COVID-19 booster shots. The Centers for Disease Control and Prevention (CDC) panel of experts has also recommended that nearly all US residents consider getting this booster. In this article, we will provide you with essential information about these new booster shots, including who should get them and why. What Did the FDA Approve? The FDA has authorized updated versions of the Pfizer and Moderna mRNA vaccines. COVID-19, like the influenza virus, continually mutates. To address this, pharmaceutical companies have developed a booster shot targeting one of the most widespread strains of COVID-19 this season, known as the XBB.1.5 variant. This fall marks the first time that adults will have access to vaccines protecting against the flu, respiratory syncytial virus (RSV), and COVID-19, all of which safeguard against commonly circulating respiratory illnesses. This year’s COVID-19 booster specifically targets the XBB.1.5 variant. Who Should Receive the New Booster […]
Down To Earth talks to doctors to get a sense of the ailments that residents of NCR are exposed to It has been more than a week of breathing heavily polluted air for Delhiites. It is safe to say that for more than 150 hours they breathed a toxic cocktail, with the air quality ‘severe’ or ‘severe +’ since October 30. Particulate matters (PM) 2.5 and 10 remained at least five times more their safe standards. These ultrafine particles can enter the respiratory system and reach the bloodstream. On an average, a person breathes 25,000 times a day. For those living in Delhi and the National Capital Territory (NCT) regions, this means breathing toxic air 25,000 times a day. Toxins once deposited in lungs cannot be cleansed. What does such continued exposure to ultrafine PM does to our bodies? According to doctors, such continued inhalation of toxic gases affects all organs and not just lungs. It even has the potential to cause hormonal imbalances. Being in such an environment full of pollutants constantly also affects the central nervous system of the brain. “Impairment in concentration abilities has been seen. There can be other short-term disturbances to what you normally do,” Prashant Saxena, who heads the department of Pulmonology […]
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans. Ivermectin Tablets USP 12 mg (Iverotaj 12) Source: https://doi.org/10.1016/j.antiviral.2020.104787 1. Introduction Ivermectin is an FDA-approved broad spectrum anti-parasitic agent (Gonzalez Canga et al., 2008) that in recent years we, along with other groups, have shown to have anti-viral activity against a broad range of viruses (Gotz et al., 2016; Lundberg et al., 2013; Tay et al., 2013; Wagstaff et al., 2012) in vitro. Originally identified as an inhibitor of interaction between the human immunodeficiency virus-1 (HIV-1) integrase protein (IN) and the importin (IMP) α/β1 heterodimer responsible for IN nuclear import (Wagstaff et al., 2011), Ivermectin has since been confirmed to inhibit IN nuclear import and HIV-1 replication (Wagstaff et al., 2012). Other actions of ivermectin have been reported (Mastrangelo […]
We have entered an age of social distancing. As we know, living as we do now slows the rise of the Covid-19 pandemic by reducing the number of interactions people have in a day, limiting the virus’ capacity to spread. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
Elevating Standards in Manufacturing Ensuring Excellence in Quality Management Systems for Unmatched Product Quality In the dynamic landscape of pharmaceutical and manufacturing industries, adherence to stringent quality and regulatory standards is paramount. This article delves into the salient features of our Quality Management Systems, emphasizing an integrated approach towards quality control, quality assurance, production, and regulatory affairs. The Pillars of Quality Management Systems Quality management is the linchpin of our operations, ensuring that each product that leaves our facility meets the highest standards. Let’s explore the key elements that underscore the robustness of our Quality Management Systems. Integrated Approach for Seamless Quality Assurance EU-GMP PICs Certification Taj Pharma’s Global Commitment to Quality Our commitment to quality begins with an integrated approach that intertwines quality control, quality assurance, production, and regulatory affairs. This holistic strategy ensures that every step of the manufacturing process aligns with the highest quality standards set by regulatory authorities. State-of-the-Art Analytical Instrumentation At each manufacturing step, we employ state-of-the-art analytical instrumentation to monitor product quality meticulously. This advanced technology allows us to maintain precision and accuracy, ensuring that our products consistently meet or exceed industry standards. Continuous Improvement as a Quality Imperative Our dedication to quality extends […]
Fun fact: Radish greens make greatpesto. Toss them in the blender with some oil and garlic and whatever nuts and/or cheese you can scrounge up and you’ve got yourself a killer sauce. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications The direction comes against reports of global shortages of the critical drug. Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications. The new wave came as a surprise after production was not continued as many countries were more focused on vaccination. The countries such as Venezuela has decided to procure remdesivir injections from Indian firms who can export, so that they could be provided treatment of critical COVID-19 patients from the economically weaker sections.
India is home to highest number of drug-resistant TB patients Administering anti-malarial drug Chloroquine (CQ) with anti-TB drugs can reduce the tolerance of the TB bacteria, mycobacterium tuberculosis (Mtb), towards it. That, in turn, can help fight drug-resistant TB, according to a new research whose findings were published in Science Translational Medicine, a journal of American Association for the Advancement of Science. The first-of-its-kind research was conducted on mice by scientists from the Indian Institute of Science in collaboration with the National Centre for Biological Science and Foundation for Neglected Disease Research. If it translates into positive results for clinical trials on humans, it will be an important milestone for India. The country has the most number of TB and drug-resistant TB cases, according to the Global TB report 2019. India contributed to as many as 27 per cent of the world’s drug-resistant TB cases, followed by China (14 per cent). That means India harbours 130,000 drug-resistant TB cases. A challenge in TB treatment is that it takes six months or more as the bacteria persists in the body for long and strongly fights the drug. The drug thus takes long to kill the bacteria. The duration gives the bacteria enough time […]
COVID-19 Taj Pharma CEO Generics Supply COVID-19 trials COVID-19 treatments Generics Supply Centers COVID-19 clinical trials coronavirus ongoing trials Coronavirus Cases in India breaking news updates on Coronavirus in India Coronavirus updates Latest Coronavirus News Coronavirus new cases outbreak of coronavirus disease (COVID-19)
Taj Pharma India | Taj Pharmaceuticals India | Taj Pharma | Taj Pharma Hyderabad | Taj Pharma Mumbai | Taj Pharma Bombay | Taj Pharma News | Taj Pharma India News | Taj Pharma Updates | Taj Pharma Products | Taj Pharmaceuticals Products | Taj Pharma Owner | Taj Pharma CEO | Taj Pharmaceuticals CEO | Taj Pharma Jobs | Taj Pharma Vacancy | Taj Pharma Review | Taj Pharma Director
‘No one has a real idea of what the total demand is likely to be before the epidemic ends’ “Close the borders! Ground the planes!” Such responses are natural and understandable, but, taken too far, may become counterproductive. Social distancing for individuals is an unfortunate necessity; for countries, the reflex threatens to turn into a terrible policy. The same hoarding impulse to take care of your own, which has led to unnecessarily empty toilet paper shelves all over the world, may exacerbate a far more serious shortage: getting ventilators to the people who need them.
While over 50 different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States It has been more than a decade since Indian pharmaceutical companies began looking at the biosimilar opportunity. It is not an easy space to be in and quite unlike their traditional stronghold of generics. However, it is a space that is linked to the nature of future drugs – today, as is often quoted by pharma experts, one out of every three new drugs approved in the global matkets is a biotech drug, specially in fields like cancer care. While over 50 (and counting) different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States. So far, hardly a couple of Indian companies have been able to do this and much of this happened in the decade that has just concluded. In February 2015, Intas Pharmaceuticals became the first Indian company to get a biosimilar registered – the biotech drug Filgratsim under the brand Accofil – in the European Union. It is now getting ready to foray into US with more products. “We launched pegylated granulocyte-colony […]
Introduction: Unveiling the Global Leader in Generics In the bustling landscape of pharmaceuticals, Taj Pharmaceuticals Limited emerges as a beacon of innovation and excellence. Headquartered in Mumbai, India, this pharmaceutical powerhouse boasts a product range exceeding 4600 compositions across all therapeutic categories. From prescription solutions to lifesaving drugs, veterinary products to CNS drugs, Taj Pharma stands at the forefront of the industry. Taj Pharmaceuticals: A Glimpse into the Product Spectrum Prescription Solutions for Diverse Ailments Standards with Taj Pharmaceuticals’ State-of-the-Art Quality Assurance Taj Pharmaceuticals addresses a myriad of health concerns, including anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases. The company’s commitment to providing solutions for both common and critical health issues is evident in its extensive product lineup. Global Leadership in Generics Taj Pharmaceuticals has secured its position as a global leader in generics, ranking among India’s top ten pharmaceutical companies. Specializing in therapeutic areas such as cancer, virology, and transplantation, Taj Pharma’s impact reverberates worldwide. Integrated Healthcare Solutions: The Taj Pharma Approach The synergy of Taj Pharma’s generics and pharmaceutical businesses, combined with expertise in emerging genetic sciences, empowers the company to develop integrated […]
Inflammatory bowel illnesses (IBD) like Crohn’s disease and ulcerative colitis are treated with mesalamine tablets, which provide patients with focused relief. These pills for oral use include mesalamine, an anti-inflammatory compound that works locally on the irritated gut lining. They relieve symptoms like gastrointestinal discomfort, diarrhea, and rectal bleeding by lowering inflammation. Mesalamine is used to treat ulcerative colitis Mesalamine tablets are available in a variety of forms, including delayed-release and extended-release, allowing for customized treatment strategies. In addition to providing patient comfort, this adaptability reduces systemic side effects. Mesalamine tablets are an excellent way to treat IBD, promoting remission and improving the quality of life for many people who are dealing with these chronic diseases. Mesalamine Tablets Manufacturers: Your Source of Quality and Trust Taj Pharmaceuticals Limited is a prominent name among Mesalamine Tablets Manufacturers in India. Their tablets are made with extreme care and adhere to strict pharmaceutical standards. Modern production facilities used by the company, along with strict quality control procedures, guarantee that each tablet contains the exact amount of mesalamine needed for therapeutic success. But why choose Mesalamine Tablets from Taj Pharmaceuticals Limited over other manufacturers? Let’s delve into the details. How do Mesalamine Tablets Work? […]
In the ever-evolving pharmaceutical industry, choosing the right manufacturing partner is a pivotal decision. Taj Pharmaceuticals, a global player with an unwavering commitment to quality and excellence, stands out as a beacon of trust and innovation. In this comprehensive guide, we delve into the myriad facets that make Taj Pharmaceuticals the ultimate destination for contract manufacturing of export-quality pharmaceutical products. Unveiling Taj Pharmaceuticals: Your Trusted Partner A Global Presence Contract Manufacturing Export Quality Products Taj Pharmaceuticals is not just another pharmaceutical manufacturing company; it’s a global phenomenon. With a presence in over 46 markets worldwide, Taj Pharmaceuticals has solidified its reputation as a leading player in the industry. This extensive global reach ensures that your products can find a home in diverse markets across the world. A Multifaceted Product Range With a catalog boasting over 1000+ products, Taj Pharmaceuticals excels in manufacturing various pharmaceutical forms, including General Tablets, Capsules, Cream, Ointment, Jelly, Controlled and Psychotropic substances. Our diverse product range allows us to cater to a broad spectrum of therapeutic categories, giving you the flexibility you need to meet market demands. Ensuring Quality and Compliance WHO – GMP Certification Taj Pharmaceuticals operates under the strictest quality standards. Our manufacturing facility […]
Scientists say a moonshot effort is needed to end social distancing and this pandemic. Will leaders listen? The failures of the United States’ initial response to the Covid-19 pandemic are already well established: Officials were too slow to recognize the threat of the disease and too slow to get diagnostic testing in place, and were ill prepared for the strain on our health care system.
India reported the first confirmed case of the coronavirus infection on 30 January 2020 in the state of Kerala. The affected had a travel history from Wuhan, China.
Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. Taj Covi Safe Kit is currently indicated in the first line treatment for COVID-19 positive patients.
The crisis in access to essential medicines in India: key issues which call for action Author: Anurag Bhargava, SP Kalantri | DOI: https://doi.org/10.20529/IJME.2013.028 Abstract The government is planning to introduce free generic and essential medicines in public health facilities. Most people in India buy healthcare from the private sector, a compulsion that accounts for a high proportion of healthcare-related expenditure. To reduce the burden of healthcare costs, the government must improve availability and affordability of generic and essential medicines in the market. It can do so because India’s large pharmaceutical industry is a major source of generic medicines worldwide. In this article, we discuss three factors that have impeded access to generic and essential medicines: mistaken notions among policymakers, prescribers and patients about branded drugs and generic drugs in India; high prices of medicines due to the progressive dismantling of the system of regulation of medicine prices, and a drug approval and regulatory system that allows medicines (including fixed dose combinations) of doubtful efficacy, rationale, safety and public health relevance to dominate the market at the cost of access to affordable generic and essential medicines. The consequences of ill-health and wasted expenditure on drugs raise issues of public health ethics. […]
We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Considering the current situation across the globe wherein everyone is trying their best to tackle the Coronavirus pandemic, we understand that we aren’t insulated from any uncertainties too. We, as an organisation, are doing our bit to ensure the safety and security of our employees, partners, etc. while ensuring that the work isn’t hampered. coronavirus As a firm, we have always placed the highest emphasis on delivering quality generics to all our clients, consistently. I want to take this opportunity to assure you that our professional commitments continue to occupy an important place for all of us at Taj Pharmaceuticals even as we steer our way through the crisis. Our Values of Care and Working Together come to fore in difficult […]
The Future of the Pharmaceutical Industry in India: Navigating Challenges and Opportunities The COVID-19 pandemic has not only been a global health crisis but has also unleashed economic challenges across various industries. This tumultuous period has particularly emphasized the urgency for India to achieve self-reliance, a narrative captured by the ‘Atmanirbhar Bharat’ initiative. However, the ongoing pandemic has brought to light the vulnerabilities of India’s pharmaceutical sector, especially in terms of overdependence on imports for crucial medical supplies. Overdependencies on Global Markets India has earned its reputation as a leader in the global pharmaceutical landscape, boasting the largest number of US-FDA compliant Pharma plants and a significant share of WHO-GMP approved facilities. Despite these accomplishments, the Indian pharmaceutical industry ranks as the 14th largest globally, with exports contributing only 3.5% to total pharmaceutical exports. Pharmaceutical Industry in India The sector excelled in formulations and indigenous medicines, but gradual liberalization led to an influx of imports, particularly from China. Approximately 70% of India’s pharmaceutical requirements depend on Chinese imports, especially for Active Pharmaceutical Ingredients (APIs), the essential components for drug formulations. China’s cost-effective technologies, large-scale manufacturing, and supportive government policies made it a dominant force in API production, causing the shutdown […]
Here’s the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and spreading its tentacles across the world. Update: DBS evacuates 300 after one is infected – Singapore’s DBS bank has evacuated 300 employees after one employee was confirmed to have contracted the coronavirus. Japan cruise cases increase to 174 – The total confirmed cases on the Diamond Princess cruise ship, quarantined in Japan, have surged to 174. Death toll reaches 1,115; recoveries rise – Deaths from the new coronavirus have reached 1,115, while the total number of cases exceeded 45,100, including 44,653 reported in mainland China by authorities as of the end of 11 February. – According to NHC official Mi Feng, the proportion of recovered patients in China increased to 8.2% as of 10 February, from 1.3% on 27 January. WHO gives name to new coronavirus disease – The WHO has officially named the disease caused by the new coronavirus as ‘Covid-19’. – Ukraine is screening five of its citizens for the novel coronavirus, Health Minister Zoriana Skaletska said at a press briefing on 11 February. – According to Skaletska, three of the five suspected patients returned from China while the remaining two were in […]
Global Call To Action on Familial Hypercholesterolemia: Aims to Improve Diagnosis and Treatment Worldwide The FH Foundation and the World Heart Federation announced today a Global Call to Action on familial hypercholesterolemia (FH), a vastly under-recognized and poorly managed public health concern. Published in JAMA Cardiology and authored by a global panel of scientific experts, advocacy leaders, public health officials, and individuals with FH from 40 countries, the report notes glaring gaps in screening and guideline-based care for FH, the most common cause of early and aggressive heart disease. FH is an inherited metabolic disorder found in all races and ethnicities and impacts 34 million people worldwide. FH causes high LDL-cholesterol from birth and should be diagnosed and treated within the first two decades of life. Left untreated, individuals with FH have a 20-times higher risk of illness and death from cardiovascular disease (CVD). However, if diagnosed and treated, heart attacks, strokes and the need for surgery can be prevented. The international coalition was convened by the FH Foundation and World Heart Federation to reexamine and update key recommendations issued by the World Health Organization (WHO) in their report on Familial Hypercholesterolemia in 1998. In the 20 years since that report, […]
An angiogram is an X-ray of the blood vessels. They can provide images of the blood vessels in many different organs. As a result, they often help doctors diagnose conditions affecting the heart, brain, arms, or legs. Angiograms can help doctors detect blood vessel abnormalities, including weakened blood vessels, plaque deposits, and blood clots. This articles discusses why doctors use angiograms, how they perform them, and the risks and side effects associated with the procedure. It also provides tips for people recovering from an angiogram. What is an angiogram? The term “angiogram” refers to a number of diagnostic tests that doctors can use to identify blocked or narrow blood vessels. Angiograms also help doctors diagnose a range of cardiovascular diseases, including coronary atherosclerosis, vascular stenosis, and aneurysms. To perform a traditional angiogram, a doctor inserts a long, narrow tube called a catheter into an artery located in the arm, upper thigh, or groin. They will inject contrast dye into the catheter and take X-rays of the blood vessels. The contrast dye makes blood vessels more visible on X-ray images. Not all angiograms involve X-ray machines, however. Doctors can also perform angiograms using CT scans and MRI scans. A doctor may […]
The medical research community is collaborating in unprecedented ways, and working overtime, to fight COVID-19. Academics, public health agencies, biotech, and big pharma are working together to repurpose existing drugs, develop new therapies and protect us with new vaccines. What can we expect them to deliver — and when?
A simple glossary of complicated and previously obscure words related to the pandemic. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. Our drug Ranitidine Tablets are safe: Taj Pharmaceuticals Amid a raging controversy over commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited today said that its formulation drug is safe. The company said that the test results found that Taj Pharmaceuticals’ Ranitidine tablets was within the “acceptable limits” for the presence of a probable cancer causing substance. On 29th September 2019 US FDA had raised a global alarm over the presence of a probable cancer causing substance—NDMA or N-Niteosodimethylamine—in some Ranitidine medicines. The company is likely to continue Ranitidine drug sale, following the report. “The Company intends to provide additional updates in the next coming days, including potential recommencement,” it said in a statement. Taj Pharma Ranitidine Free of ALL NDMA / NDEA Impurities NDMA Risk Assessment Report is done in much more advanced for all potential APIs (Valsartan) on our ROS of Ranitidine Hydrochloride and analyzed few batches for NDMA content in Ranitidine HCL API by validated LC-MS/MS and GC-MS methods. As per our initial investigation and assessment report, it is found that the formation of NDMA in ROS of our […]
New Covid variant Eris symptoms appear a week before positive test? Know all about this ‘pre-Covid’ phenomenon In the ever-evolving landscape of the COVID-19 pandemic, new variants continue to emerge, each with its own set of characteristics and challenges. Among the latest variants to capture attention is the Eris variant, specifically EG.5. This variant has been spreading rapidly in various parts of the world, raising concerns and questions about its symptoms and detection. Understanding the Eris Variant EG.5, a sub-variant of the coronavirus, has garnered attention for its ability to spread quickly. However, experts have noted that the symptoms associated with this variant are relatively mild, and it doesn’t pose a significant threat in terms of severity. Despite this, EG.5 has been declared a variant of interest, and health authorities are closely monitoring its mutations. It’s worth noting that the rapid spread of EG.5 has led to some intriguing observations in the form of a ‘pre-Covid’ phenomenon. The ‘Pre-Covid’ Phenomenon What is the ‘pre-Covid’ phenomenon, and why are people reporting it in connection with EG.5 and other Omicron variants? To understand this, we need to delve into the incubation period of the virus. When a person contracts a virus like […]
FDA approves new generic valsartan to make up for drug shortage Generic valsartan Taj Pharmaceuticals (CNN)- The US Food and Drug Administration approved a new generic of valsartan on Tuesday to help relieve the recent shortage of the medicine, which is used to treat high blood pressure. Since last summer, the FDA has issued multiple recalls of generic valsartan medications from several manufacturers after discovering that certain lots contained nitrosamine impurities that pose a cancer risk to patients. The FDA discovered impurities in only the generic, not brand-name, valsartan, which is a form of angiotensin II receptor blockers, or ARBs. Common heart drug recalled in 22 countries for possible cancer Following the initial recall, the FDA found that other types of generic ARBs, those containing either losartan or irbesartan as the active ingredient, had also been tainted with impurities. “We know that the ongoing recalls to prevent certain lots of valsartan that contain unacceptable limits of impurities from reaching patients has resulted in a shortage of these important medicines,” FDA Commissioner Dr. Scott Gottlieb said in a statement Tuesday. The FDA prioritized review of the newly approved generic version of this medicine to address this shortage, he said.Sometimes one company’s […]
Nigeria, the most populous country in Africa, is a nation of rich history and diverse cultures. In this article, we delve into the multifaceted landscape of Nigeria, exploring its political history, demographic diversity, and the pharmaceutical industry, with a focus on Taj Pharmaceuticals’ role in this dynamic market. Nigeria: A Historical Perspective Nigeria Country Profile Nigeria’s modern state owes its present territorial shape to 19th-century British colonialization. This diverse nation, inhabited by over 250 ethnic groups speaking more than 500 distinct languages, achieved independence in 1960. However, its journey to political stability was marked by a civil war from 1967 to 1970, when the breakaway state of Biafra declared independence. The political landscape of Nigeria saw a succession of military dictatorships and civilian governments until the establishment of a stable democracy in the 1999 presidential elections. This diverse ethnic and cultural nation has faced challenges in preventing ethnic and religious divisions, with separatist aspirations gaining traction. Nigeria’s Complex Security Challenges Nigeria’s security landscape is multifaceted and poses significant challenges to the federal government. These challenges include: Jihadist Insurgency in the North: The northern region faces a persistent jihadist insurgency. Herder-Farmer Clashes: Conflicts between animal herders and farmers over water and […]
Big Pharma Bets on Body’s Garbage-Disposal System to Beat Cancer New drugs called “degraders” could take disease-causing proteins out with the trash. Craig Crews pioneered protein degrader drug technology. At their most basic level, many of the deadliest diseases are caused by nests of misguided proteins. Most medicines work by attaching themselves to these proteins and temporarily shutting them down. In the 1990s, Yale University scientist Craig Crews and a colleague had a radical idea: What if a drug could destroy a bad protein by making it a target of the body’s own molecular trash disposal machines? For years, the idea remained a lab curiosity. Biotech investors wouldn’t initially back a company based on the concept, which Crews and a few other academics labored to prove could be a practical way to make drugs. The field got a big boost earlier this decade when scientists started discovering that some of the most successful medicines turned out to work by piggybacking onto these human trash collectors. Now it’s become one of the hottest new technologies for making pills. Crews and a biotech he founded, Arvinas Inc., are racing some of the world’s biggest pharmaceutical and biotech companies—Novartis, Amgen, and Gilead Sciences—to […]
Eating chilies cuts risk of death from heart attack and stroke, Research Says {Taj Pharmaceuticals} That delicious penne all’arrabiata may have benefits that go further than putting a smile on your face, according to a new study. For many years, chili has been hailed for its therapeutic properties, and now researchers have found that eating chili peppers regularly can cut the risk of death from heart disease and stroke. Carried out in Italy, where chili is a common ingredient, the study compared the risk of death among 23,000 people, some of whom ate chili and some of whom didn’t. Participants’ health status and eating habits were monitored over eight years, and researchers found that the risk of dying from a heart attack was 40% lower among those eating chili peppers at least four times per week. Death from stroke was more than halved, according to results published Monday in the Journal of the American College of Cardiology. “An interesting fact is that protection from mortality risk was independent of the type of diet people followed,” said study lead author Marialaura Bonaccio, an epidemiologist at the Mediterranean Neurological Institute (Neuromed). “In other words, someone can follow the healthy Mediterranean diet, someone […]
Indian pharmaceutical market update Generic affordable alternatives are much more easily available India With around 1.3 billion residents, India is home to just a fraction fewer people than China, the world’s most populous nation. India is also developing fast, consistently posting annual gross domestic product (GDP) growth rates in the mid-to-high single digits since the turn of the millenium, and outpacing all other nations in 2018 with growth of 7.3%. The country’s GDP is now roughly equivalent to that of the UK in nominal terms. Adjusting for purchasing power differences it is the third largest, behind the USA and China. Despite these impressive figures, hundreds of millions of people live in poverty. India remains a developing nation, with a healthcare system to match. At around $30 billion, the country’s pharmaceutical market generates revenues roughly equivalent to those of the newly-enlarged Japanese drugmaker Takeda Pharmaceutical (TYO: 4502). The market for pharmaceutical products does not, therefore, move the needle for global drugmakers, but as it continues to grow in line with wider economic development, new opportunities will continue to emerge. “By 2020, the value of pharma products sold in the country is is expected to reach $55 billion.” By 2020, the value […]
Management of mild to moderate COVID-19 during the wave in India; Doctor Believes Ivermectin Drug Can Help With COVID-19 taking a tight grasp on the lives of people in India and around the world, experts have been tirelessly searching for existing medications that can help combat this relentless virus. While vaccines like Pfizer, Moderna, and AstraZeneca have been pivotal in the fight against COVID-19, there’s a growing interest in repurposing drugs. Among them, one that has gained significant attention is Ivermectin. In this comprehensive article, we delve into the potential of Ivermectin in managing mild to moderate COVID-19 cases, its history, and its current status in India. Ivermectin: The Wonder Drug? Ivermectin Tablets USP 12 mg (Iverotaj 12) Ivermectin, an anti-parasitic drug, has a storied history. It has proven beneficial in treating various tropical diseases, including onchocerciasis, helminthiases, and scabies. However, its origins lie in veterinary medicine. In the 1960s, Satoshi Omura, a microbiologist at Tokyo’s Kitasako Institute, and William Campbell from New Jersey discovered that a culture of bacteria known as Streptomyces avermictilis was effective against worms. They later chemically modified its active component, avermectin, making it safer and more effective. This led to the birth of Ivermectin, which […]
New research in mice shows “for the first time” that scientists can use protons to administer radiation therapy in a matter of milliseconds, killing cancer cells while protecting healthy tissue. Over half of the people with a cancer diagnosis receive radiation therapy. Radiation damages the DNA of cancer cells, either slowing their progression or killing them. However, this is a slow process; radiation does not destroy cancer cells right away — sometimes it takes weeks of treatment to damage the DNA of the cells enough to kill them. A further reason why radiation treatment can take several weeks is that the therapy is most likely to succeed when cancer cells are growing and dividing into new cells. So, spreading the treatment over a long period increases the chances that the radiation will target cancer cells when they are in a growing phase. Finally, administering radiation in small, daily doses helps protect healthy cells by giving them more time to repair. But new research suggests that there may be a way to administer radiation at record speed while also protecting healthy tissue. The innovative technique is called FLASH, or ultra-high dose rate radiotherapy, and according to previous research, it uses electrons […]
The first biosimilar in India was approved in 2000, and, with the help of legislation and regulation from the Indian Government, the market has continued to grow since, reaching a value of $2.2bn in 2017. However, biosimilars remain challenging to manufacture for Indian pharmaceutical companies, at the emerging end of the market. India has firmly established itself in the global pharmaceutical market; it has been predicted that India will be the sixth largest market for pharmaceuticals by 2020, and the country exported pharmaceutical products worth more than $17bn in 2017-8. Indian pharmaceutical companies are especially known for producing generics, identical copies of branded drugs marketed under different names once the patent for the original drug has run out. Many of these companies are starting to move into the global biosimilars market. According to Associated Chambers of Commerce of India’s 2017 report, biosimilars are worth $2.2bn out of the $32bn total Indian pharmaceutical market and are expected to reach $40bn by 2030, which represents a 30% compound annual growth rate. This growth will be aided by a range of biologic patents expiring in the next few years. Biosimiliars are medicines that are highly similar and clinically equivalent to complex, biologic medicines […]
Govt’s generic push will dent Rs 90,000-cr branded pharma market Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Medicines Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a public event on Monday. The health ministry has now started working on amending the Drugs and Cosmetics Act to this effect. “Indian patients may face quality issues without price benefit as intense competition among marketers will lead to incentivising a chemist,” says D G Shah, secretary-general of the Indian Pharmaceutical Alliance. India, like most of other emerging markets, is predominantly a branded generics play with a 90 per cent share in the Rs 1-lakh-crore market. Which means that drug makers sell these off-patent drugs through their relationships with doctors. In developed countries such as the US, only patented drugs are sold under a brand, which is marketed through their ties to doctors. Off-patent drugs are sold only as pure generic, without using any brand name. It helps in making pure generics cheaper. It is this nexus […]
China coronavirus: All you need to know – A new virus has killed 81 people in China and infected almost 3,000 people, with cases confirmed in several countries. Coronavirus: Everything you need to know Health authorities around the world are grappling with an outbreak of a new coronavirus, which originated in the Chinese city of Wuhan. At least 81 people have died in China and almost 3,000 have been infected worldwide. What is a coronavirus? Coronaviruses are a large family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), according to the World Health Organization (WHO). They circulate in animals and some can be transmitted between animals and humans. Several known coronaviruses are circulating in animals that have not yet infected humans. The new coronavirus has been named novel coronavirus (2019-nCoV). It is the seventh coronavirus known to affect humans. What are the symptoms? Common signs of infection include fever, coughing and breathing difficulties. In more severe cases, infection can cause pneumonia, SARS, kidney failure and death. The incubation period of the new coronavirus is thought to be between one and 14 […]
Reports suggest such is the medicine residue in water bodies that fish is changing character; oral contraceptive residue makes them ‘feminised’ Imagine this pollutant: It treats illness, but when it escapes into the environment it remains there; unregulated, it keeps affecting millions, making them further ill. Many of them end up with damaged organs. It not only impacts unsuspecting humans, but also other living beings. To sum up, the new pollutant is an agent of mass health disruption — it is the residue of our medicines, or pharmaceuticals, left unregulated and untreated. A new study by the Organisation for Economic cooperation and Development (OECD) has found that a “vast majority” of the 2,000-odd active ingredients in use in human and veterinary medicines are not regulated. They have not been yet evaluated for their risks once they escape to the environment. Every year more and more such active ingredients are approved for use. Thus, it adds to the pile of such unregulated residues in the environment. Residue of medicines enters into our environment — water bodies, streams, air and food — at all the stages of medicine preparation starting from manufacturing, uses and disposal. But the biggest source of it is the natural process of medicine absorption by […]
This is how HIV decides to become active Researchers have found the molecular mechanism underpinning HIV’s decision to remain in an active or dormant state. This may lead to new therapies that work by keeping the virus in a permanently dormant state. The study, led by a team from the Gladstone Institutes in San Francisco, CA, features in a paper now published in the journal Cell. The findings may also explain cell fate decisions that occur elsewhere in biology — such as how stem cells decide whether to remain as stem cells or differentiate into specialized cells, including brain or heart cells, when they divide. Senior study author Prof. Leor S. Weinberger, the director of the Center for Cell Circuitry at the Gladstone Institutes, likens the process to how we “hedge our bets” when we make decisions about financial investments. To “protect against volatility in the market,” we may choose to place some funds in high-risk stocks with potentially high yields and the rest in low-risk, low-yield options. “Similarly,” he explains, “HIV covers its bases in a volatile environment by generating both active and dormant infections.” HIV latent reservoir: Once it enters the human body, HIV inserts its genetic material […]
When it comes to Deferasirox tablets, Taj Pharmaceuticals Limited stands tall as a trusted name in the industry. Our commitment to producing high-quality Deferasirox tablets has earned us a strong reputation as one of the leading Deferasirox Tablet Manufacturers in India. In this comprehensive guide, we delve into the world of Deferasirox tablets, their uses, and why choosing Taj Pharmaceuticals Limited as your supplier is a wise decision. Deferasirox Tablet: An Overview What is the Deferasirox Tablet? Deferasirox is a vital medication used in the treatment of chronic iron overload, a condition often seen in patients requiring regular blood transfusions due to diseases like beta-thalassemia and other chronic anemias. The repeated transfusions lead to an accumulation of excess iron in the body, a situation that can have dire consequences if left untreated. Deferasirox comes to the rescue by aiding the body in eliminating this surplus iron, thus preventing organ damage and other associated health issues. Taj Pharmaceuticals Limited: Your Trusted Deferasirox Tablet Manufacturer As one of the foremost Deferasirox Tablet Manufacturing Companies in India, Taj Pharmaceuticals Limited takes pride in being the manufacturer of choice for healthcare professionals and patients alike. Our Deferasirox tablets have garnered respect and trust for […]
— Drug to be given to comatose Illinois patient after docs refusedby Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today May 4, 2021 Ivermectin Tablets USP 12 mg (Iverotaj 12) An Illinois judge has ordered a hospital to give ivermectin to a comatose patient with few options left. Judge James Orel of DuPage County ordered Edward-Elmhurst Hospital to allow 68-year-old COVID-19 patient Nurije Fype to receive the drug, even though it isn’t endorsed by federal health agencies, the Chicago Tribune reported. Fox 32 Chicago reported that Fype, who has been in the intensive care unit since early last month and is currently on a ventilator, has since received her first dose. Her daughter, Desareta Fype, enlisted the help of a New York law firm that has taken on other ivermectin cases to force the hospital’s hand after none of its doctors would agree to administer the drug, according to the local media outlets. The Tribune reported Tuesday that an outside doctor was granted credentials at the hospital to administer the ivermectin. “‘Why wouldn’t this be tried if she’s not improving?’” the Tribune quoted Judge Orel as saying during a court hearing. “‘Why does the hospital object to providing this medication? […]
Introduction: A Legacy of Quality and Innovation In the dynamic world of pharmaceuticals, Taj Pharmaceuticals stands tall as a leader in the manufacturing of generic finished formulations. With a state-of-the-art dedicated manufacturing facility in India, Taj Pharma has not only gained a competitive edge in cost but has also become the ideal sourcing partner for a global clientele. Taj Generics: Redefining Pharmaceutical Standards 1. Taj Generics by Taj Pharma Generic Pharmaceuticals Taj Generics, the generic pharmaceutical arm of Taj Pharma, is making waves as one of the leading players in the industry. Holding top positions in established markets and expanding its presence in emerging markets, Taj Generics offers a vast portfolio of over 500 branded and 4600 generic compositions across 40 countries. 2. Understanding Generic Drugs A generic drug is more than just a cost-effective alternative. It mirrors the approved brand-name drug in dosage, safety, strength, route of administration, and performance characteristics. Taj Generics ensures that the active ingredients align with brand-name drugs, delivering the same therapeutic effect. The Taj Pharma Advantage: Beyond Numbers 3. Taj Pharma’s Global Reach With a presence in over 40 countries, Taj Pharma has become synonymous with trust. Boasting a diverse product range covering various […]
‘A combination of approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA and TGA approved Ivermectin which he uses regularly in his hospital, has shown positive results for COVID-19 and should be considered immediately to fight the pandemic. Ivermectin was discovered in the 1970s and is on the World Health Organization (WHO) list of essential medicines. Professor Borody has used the same methodology with the COVID-19 Ivermectin Triple Therapy as he used when he developed the world’s first cure for peptic ulcers saving millions of lives around the globe. He says this combination of 3 approved “off the shelf” drugs could be the answer to Australia’s COVID-19 crisis. “If nothing else, make it available in aged care homes immediately. Our elderly are at the highest risk and this is a very safe option especially when we have nothing else except ventilators. Also, our frontline workers deserve more protection with a preventative […]
Choirs are a secret lifeblood of our country. It’s unclear when and how we’ll ever sing together again. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
I. Introduction A. Brief overview of Taj Pharma B. Headquarters and specialization II. Formulation Development A. In-house process equipment B. Dosage forms offered 1. Injectable 2. Oral Solids 3. Oral Liquids 4. Semisolids III. Oral Solids A. R&D support for tablets B. Development of capsules C. Powder for oral solutions/suspensions IV. Injectable Capabilities A. Development of aqueous and non-aqueous injections B. Ophthalmic solutions C. Lyophilized products V. Nutraceuticals A. Impressive group available for tech transfer B. Out-licensing opportunities VI. Achievements and Track Record A. Products filed with USFDA B. Successful approvals and commercialization VII. Collaborations A. Partnerships with renowned pharma companies B. Highlight of successful collaborations VIII. Essential Services A. Dossier Development B. Tech Transfer C. Commercial Supply D. BA/BE, CT, and Nutraceutical product supply IX. Invitation to Explore Opportunities A. Call to action for potential partnerships B. Eagerness to discuss possibilities X. Conclusion A. Expressing confidence in collaboration B. Gratitude for considering Taj Pharma XI. FAQs A. Frequently asked questions about Taj Pharma and its services Taj Pharma: Revolutionizing Pharmaceutical Development Pharmaceutical Manufacturing Partner In the bustling world of pharmaceuticals, one name stands out for its commitment to excellence and innovation – Taj Pharma. Headquartered in Mumbai, Taj Pharma, […]
Ranitidine, a widely prescribed medication for combating acidity, has long held a place on the World Health Organization’s Model List of Essential Medicines. Amidst recent concerns and controversies surrounding the commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited has asserted the safety of its formulation. This article delves into the details surrounding Taj Pharmaceuticals’ Ranitidine tablets and their commitment to ensuring safety. The Ranitidine Controversy On September 29, 2019, the U.S. Food and Drug Administration (FDA) raised a global alarm regarding the presence of a probable cancer-causing substance known as NDMA or N-Niteosodimethylamine in some Ranitidine medicines. This revelation sent shockwaves through the pharmaceutical industry, prompting extensive investigations and safety assessments. Taj Pharmaceuticals’ Assurance Ranitidine Tablets 150mg Taj Pharmaceuticals Limited, in response to these concerns, conducted rigorous tests to determine the safety of their Ranitidine tablets. The results of these tests found that Taj Pharmaceuticals’ Ranitidine tablets fell within the “acceptable limits” for the presence of NDMA, the aforementioned cancer-causing substance. This assurance from Taj Pharmaceuticals is a significant development for patients and healthcare professionals alike. Resumption of Ranitidine Sales Following the reassuring test results, Taj Pharmaceuticals is poised to continue the sale of Ranitidine drugs. In a statement, […]
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. Ivermectin tablets USP 12 mg (Iverotaj 12) The study also found that ivermectin was “associated with reduced inflammatory markers” and quicker viral clearance. Ivermectin, a widely available inexpensive drug used to treat worm and scabies infections in humans and animals, has emerged as a COVID-19 treatment in several parts of the world. Its use, however, has been controversial. WHO has counseled against its use as a COVID-19 treatment outside of clinical trials. And Merck, an ivermectin manufacturer, released a statement in February saying there was no scientific evidence to support the use of ivermectin for COVID-19. A study recently published in the American Journal of Therapeutics also found some benefits for ivermectin in treating COVID-19 with moderate-certainty evidence. The data from the study published in Open Forum Infectious Diseases is unlikely to convince skeptics. Nine of the studies involved in the meta-analysis were preprints. Another […]
A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Pharma Manufacturers The coating of tablets plays a pivotal role in enhancing not only their appearance but also their overall functionality. Tablets can be coated for various reasons, whether it’s to improve taste, stability, ease of swallowing, or to modify their release properties. This article delves deep into the world of pharmaceutical tablet coating, exploring the different types, materials used, and the advantages they offer. At Taj Pharmaceuticals, we take pride in our cutting-edge technology and adherence to cGMP guidelines, ensuring that our tablet coating processes meet the highest standards of quality and effectiveness. The Importance of Tablet Coating Tablet coating is a critical step in pharmaceutical manufacturing, and it serves multiple purposes that contribute to the quality and efficacy of the final product. Here are some key advantages of tablet coating: 1. Enhancing Taste, Odor, and Color Coating materials can significantly improve the sensory aspects of a drug. By masking unpleasant tastes or odors and adding vibrant colors, coatings make medications more palatable and visually appealing to patients. 2. Improved Ease of Swallowing Many patients struggle with swallowing large or uncoated tablets. Tablet coatings can make the process easier, especially for pediatric and geriatric populations, by reducing the tablet’s […]
More than a sixth of suicides in India in 2016 due to health reasons More than a sixth of suicides in India were due to ‘illness’, according to data recently released by the National Crime Records Bureau. Mental health issues could have played a large role in this, the data indicated. The need to prevent suicides has drawn little attention in the country though they outstrip the combined toll of AIDS and maternal death. Reducing the count by a third by 2030 is among the United Nations-mandated Sustainable Development Goal. In 2016, ‘insanity’ or mental illness, cancer, paralysis and sexually transmitted diseases such as AIDS were among the major health issues that pushed people to take their lives. Alarmingly, 932 in the category were not yet adults. Cause Below 18 years 18 – Below 30 years 30 yrs. – Below 45 years 45 yrs. – Below 60 years 60 years & above Illness (total) 932 5297 6737 5611 3834 AIDS/STD 4 42 97 35 20 Cancer 5 110 246 320 194 Paralysis 14 117 209 245 157 Insanity/ mental illness 411 2329 2733 1987 1167 An estimated 150 million Indians live with mental health disorders; only one in 10 get necessary treatment. […]
It’s complicated … most vaccines used today took between 5-15 years to perfect. Time to get a COVID-19 vaccine to market is likely to be at least 18 months.Potential treatments require testing and funding.International organizations are helping to fund research. COVID-19 is new and scientists understand little about how it behaves and spreads. The cost of creating a vaccine to protect people against the new coronavirus will run into billions of dollars and could take many months. Here are some of the reasons why. COVID-19 Vaccines are complex to make Technology is enabling new methods of exploring vaccine candidates for trial, but there are already a few tried and tested ways to make them. In all of them, scientists try to stimulate the body’s immune system to combat invasive pathogens. That’s commonly done by creating something so similar to the pathogen that the body begins to create antibodies to fight off the real thing. The most common way of doing this is to make what’s called attenuated vaccines – those that are made of weaker strains of the actual pathogen. Reared on animal cells outside of human bodies (some flu vaccines are cultured on chicken eggs), they are then extracted […]
Though bound by law, neither doctors nor pharmacies want to dispense generic medicines to patients as the profit margin is low Laws in India specify that all medical prescriptions should give generic medicines and all pharmacies must make them available to patients. “Most cancer medicines still remain unaffordable to most Indians because there is no curb on profiteering by pharma manufacturers”. But aggressive marketing by private pharma companies, cut-throat competition and ignorance of the customers coupled with weak enforcement of rules allow private manufactures of branded medicines to make a killing through your “friendly pharmacy”. About 85% of total health expenditure in India is financed by household out-of-pocket expenditure (according to government figures) and medicines constitute 20% to 60% of total healthcare expenditure. Understanding the strain medical expenditure has on the common man, the central government has been working on “aggressive” marketing of generic drugs by opening pharmacies that sell these medicines, and asking pharmacies to display availability of these medicines. Missing display Sadly almost no pharmacy in the Capital seems to be in the mood to cooperate with the government in advertising the availability of generic drugs. “We provide what doctor has prescribed” is the common refrain. But just […]
In a world that relies on advancements in medical science to treat a multitude of ailments, the unavailability of a life-saving medicine can have dire consequences. D-Penicillamine, a critical medication used in the treatment of Wilson’s disease, is currently in short supply across the country, putting the lives of many patients at risk. This alarming shortage has primarily arisen due to a lack of raw materials needed for the drug’s production, prompting the drug regulatory authorities to convene an urgent meeting with the leading manufacturers of D-Penicillamine, including Taj Pharmaceuticals. The Silent Threat: Wilson’s Disease What is Wilson’s Disease? D-Penicillamine Capsules 250mg Wilson’s disease is a rare genetic disorder that affects roughly one in every 30,000-50,000 Indians. This condition hinders the body’s ability to eliminate excess copper, leading to its accumulation in vital organs such as the liver, brain, kidneys, and eyes. If left untreated, this condition can result in severe complications. The Role of D-Penicillamine D-Penicillamine is a life-saving medication used to remove excess copper from the body by promoting its excretion through urine. This medication plays a crucial role in managing Wilson’s disease and preventing the associated complications. The Crisis: Unavailability of D-Penicillamine The current crisis stems from […]
A Partnership with Taj Pharmaceuticals Introduction In the world of pharmaceuticals, the pursuit of excellence in quality and affordability is relentless. If you’re looking for a reliable partner for contract manufacturing of export-quality products, look no further than Taj Pharmaceuticals. With a global presence and a vast array of offerings, Taj Pharmaceuticals is your one-stop solution for producing high-quality pharmaceutical products that meet international standards. Join us on a journey to explore the remarkable world of contract manufacturing with Taj Pharmaceuticals. Table of Contents Sr No.#Topics1Who Is Taj Pharmaceuticals?2Our Global Reach: Beyond Boundaries3Comprehensive Product Portfolio4Our Commitment to Quality5A Cost-Efficient Partnership6Regulatory Approvals: Your Assurance7Tailored Formulations for Diverse Therapeutic Areas8The Long-Term Partnership: A Shared Success9Unveiling Our Quality Standards10COPPs and Dossiers: Simplifying Your Path to Success11Conclusion: A Trusted Partner in Pharmaceutical Industry12FAQs: Your Questions, Our Answers13FAQ 1: How can I partner with Taj Pharmaceuticals?14FAQ 2: What sets Taj Pharmaceuticals apart from others?15FAQ 3: Are my products safe with Taj Pharmaceuticals?16FAQ 4: What therapeutic categories do you offer?17FAQ 5: What’s the process of obtaining regulatory approvals? 1. Who Is Taj Pharmaceuticals? Contract Manufacturing Export Quality Products Taj Pharmaceuticals is a globally recognized pharmaceutical manufacturing company with a rich history of producing top-notch pharmaceuticals. We […]
The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment.
Rwanda’s Pharmaceutical Industry: A Booming Sector in East-Central Africa In the heart of East-Central Africa, Rwanda is emerging as a dynamic player in the global pharmaceutical industry. This small landlocked nation, known for its tumultuous history, is now making significant strides in the healthcare sector, with a particular focus on pharmaceuticals. In this comprehensive article, we delve into the thriving pharmaceutical business landscape in Rwanda, exploring key players, challenges, and opportunities in the sector. Rwanda’s Remarkable Resilience Rwanda Country Profile Rwanda, a country marred by ethnic strife and the tragic genocide in the mid-1990s, has shown remarkable resilience in rebuilding its nation. The government’s efforts have not only led to political stability but also paved the way for economic development. Among Rwanda’s main exports, coffee and tea production stand out. These industries have not only contributed to the country’s GDP but have also played a pivotal role in reducing poverty and inequality. A Snapshot of Rwanda Before delving deeper into Rwanda’s pharmaceutical sector, let’s take a quick look at some key facts about this vibrant nation: Capital: Kigali Area: 26,338 sq km Population: 13.8 million Languages: Kinyarwanda, French, English, Swahili Life Expectancy: 64 years (men), 69 years (women) At the […]
Preschool children who had taken 2 or more antibiotic courses for acute respiratory tract infections in the preceding year had around a 30% greater chance of not responding to subsequent treatment GPs in the UK carry out over 300 million patient consultations every year and at least a quarter of these deal with children. Almost two-thirds of such appointments are for coughs, sore throats, or earaches — illnesses that young children commonly get. Doctors and nurses group these types of illnesses as “acute respiratory tract infections”. They are considered to be “self-limiting”, meaning that antibiotics have little or no benefit and that the illness will go away in time. Yet, in at least 30 per cent of these consultations, antibiotics are prescribed. That’s an estimated 13 million unnecessary antibiotic prescriptions. This is not only wasteful but may also have unintended consequences for the child’s health. Indeed, in our new study of over 250,000 children in the UK, we found that preschool children who had taken two or more antibiotic courses for acute respiratory tract infections in the preceding year had around a 30 per cent greater chance of not responding to subsequent treatment (including the need for hospital referral and admission) compared […]
What the experts say? A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
What is melanoma? | Melanoma Stages | Melanoma Types | Melanoma Risk factors | Melanoma Symptoms | Melanoma Treatment | Prevention melanoma | Melanoma Diagnosis | Melanoma Outlook Melanoma is a type of skin cancer. It is not the most common, but it is the most serious, as it often spreads. When this happens, it can be difficult to treat, and the outlook may be poor. Risk factors for melanoma include overexposure to the sun, having fair skin, and a family history of melanoma, among others. melanoma Receiving an early diagnosis and getting prompt treatment can improve the outlook for people with melanoma. For this reason, people should keep track of any changing or growing moles. Using adequate protection against sun exposure can help a person prevent melanoma altogether. This article covers the symptoms of melanoma, how a doctor would diagnose it, and ways to treat it. We also explain how best to prevent melanoma. What is melanoma? A person may be more at risk of melanoma if they have a family history of the condition. Melanoma is a type of skin cancer that occurs when pigment producing cells called melanocytes mutate and begin to divide uncontrollably. Most pigment cells […]
Half of pediatric cancers undiagnosed and untreated worldwide Nearly one in two children with cancer are never diagnosed and may die untreated, according to a a new model proposed in a study published in The Lancet Oncology by Zachary Ward and colleagues from Harvard University T.H. Chan School of Public Health. In fact, the model estimates that there were 397.000 childhood cancer cases globally in 2015, while only 224,000 had been previously recorded as diagnosed that year, leading ultimately the researchers to say that over 43% of childhood cancer cases were undiagnosed. But there was substantial regional variation: it ranges from 3% in both Western Europe (120 undiagnosed cases out of 4,300 total new cases) and North America (300 of 10,900 cases), to 57% (43,000 of 76,000 new cases) in Western Africa. With such path, at current levels of health system performances, If no improvements are made, the study authors estimated that nearly three million out of 6.7 million total cases will be missed between 2015 and 2030. Accounting for underestimation is vital: accurate estimates of incidence are important for policy makers, however, many countries do not have cancer registries that quantify that incidence (and often even if they do […]
{Taj Pharmaceuticals} Finding a cure for hepatitis B: The NIH announced a plan to “intensify” ongoing hepatitis B virus research that is focused on finding a cure and improving screening and treatment for the infection. For nearly 40 years, there has been an effective vaccine to prevent HBV, but the virus still causes an increasing number of illnesses and deaths worldwide each year. Focusing on three critical research areas, the Strategic Plan for Trans-NIH Research to Cure Hepatitis B aims to address the global public health challenge that HBV presents. Healio spoke with National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, MD, about the plan, the “crucial” role that clinicians play, and how close the world is to a cure for HBV. – by Marley Ghizzone Q: What was the impetus for the plan? A: Hepatitis B is a prevalent and serious disease. The global disease burden is approximately 257 million chronic infections worldwide — 850,000 to 2.2 million in the United States — and approximately 900,000 deaths per year, with those numbers increasing. There are new scientific opportunities to pursue due to the identification of a cell receptor for HBV, more advanced cell culture systems and […]
FDA Approves First Generic of Popular Blood Thinner The first generic versions of the powerful blood thinner Eliquis (apixaban) were approved by the U.S. Food and Drug Administration on Monday. Heparin Sodium Injection – Taj Pharmaceuticals “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in an agency news release. “These approvals mark the first generic approvals of a direct oral anticoagulant,” Woodcock noted. “Direct oral anticoagulants [blood thinners] do not require repeated blood testing.” The two types of generic tablets were approved to reduce the risk of stroke and systemic clotting in the lungs of patients with non-valvular atrial fibrillation and for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism (lung clots), in patients who have had hip or knee replacement surgery. Atrial fibrillation is a heart rhythm disorder that raises the risk of blood clots. It is estimated that between almost 3 and 6 million Americans have atrial fibrillation, according to the U.S. Centers for Disease Control and Prevention. Many of these […]
Read more on what is lung cancer here. Etoposide is the chemotherapy drug and is classified as a plant alkaloid (Epipodophyllotoxin) and a topoisomerase II inhibitor. Plant alkaloids are substances that are made from plants. Etoposide is available under the trade name VP-16 or Toposar. The drug acts by inhibiting topoisomerase II, thereby inhibiting DNA synthesis. Availability, Dosage and Administration of Etoposide Etoposide is available in tablet form and can be taken orally. It is also available in injectable form and can be administered as an infusion into the patient’s vein, it can be a short infusion or can be an infusion that lasts for over 24 hours. Availability In the oral form it is available as capsule with the dose strength of 50mg and in the injectable form it is available as 20mg/ml. Uses Small cell lung cancerNon-small cell lung cancerGerm cell tumorsNon-Hodgkin’s LymphomaStomach cancerAs a high dose therapy in the setting of transplantation. Dosage The recommended dose depends on the indication or use. It is generally given at 100 to 120 mg/m2, for 1 to 3 days, every 3 weeks. Side effects Most people do not experience side effects while being treated with etoposide. Even if side effects […]
Manufacturer of Pharmaceutical Formulations, Sterile & Critical Care Injectables: Taj Pharmaceuticals In the ever-evolving world of pharmaceuticals, Taj Pharmaceuticals stands as a beacon of innovation and excellence. With a commitment to quality, an impressive range of products, and a global presence, Taj Pharmaceuticals is a name synonymous with pharmaceutical formulation development. In this comprehensive article, we will delve into the world of Taj Pharmaceuticals, exploring its remarkable offerings, manufacturing capabilities, and the significant impact it has on the healthcare industry. Introduction WHO GMP Certification Taj Pharmaceuticals, a renowned manufacturer of pharmaceutical formulations, specializes in the production of sterile and critical care injectables. With a rich history and a commitment to excellence, this pharmaceutical giant has become a trusted name in the industry. This article will take you on a journey through their offerings, manufacturing processes, and the global reach they have achieved. The Diverse Product Range One of the key factors that set Taj Pharmaceuticals apart is its diverse product range. The company offers a wide array of pharmaceutical products, including Ampoules, Vials, Lyophilized formulations, Liposomes, and Nanoparticle products. This extensive portfolio caters to various medical needs, making Taj Pharmaceuticals a one-stop destination for healthcare professionals and patients alike. Quality […]
Tablets are one of the most commonly used solid dosage forms. These tablets are carefully crafted by compressing or molding a powdered drug into a specific shape and size. This process, known as formulation development, is a critical stage in pharmaceutical manufacturing. In this article, we will explore the fascinating world of Taj Pharmaceuticals Limited and their role in this intricate process. Understanding Tablets and Formulation Development Tablets are not just pills; they are the result of a complex formulation process. This process involves selecting appropriate excipients, binders, disintegrants, and other additives to ensure the tablet’s integrity and its ability to dissolve effectively in the body. It’s akin to creating a precise recipe, where each ingredient plays a vital role in the final product. The Pillars of Formulation Excipients: These are inactive substances that serve as the vehicle for the active drug. They play a crucial role in ensuring that the drug is delivered effectively to the body. Binders: Binders are like the glue that holds the tablet together. They provide the necessary cohesiveness to the mixture. Disintegrants: These components facilitate the tablet’s breakdown once it’s ingested, ensuring that the active drug is released and absorbed efficiently. Additives: Various additives, […]
The test can run on small machines the size of a toaster; A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Taj Pharmaceuticals Limited: Pioneering Oncology Formulation with Unmatched Excellence Unveiling Taj Pharmaceuticals Limited’s Dedication to Oncology Formulation Development In the era of pharmaceutical excellence, Taj Pharmaceuticals Limited stands as a beacon of innovation and commitment, particularly in the field of oncology formulation development. This article delves into the company’s journey, its major successes, and its notable contributions to the pharmaceutical industry. A Glimpse into Taj Pharmaceuticals Limited Taj Pharmaceuticals Redefining Excellence in Oncology Formulation Taj Pharmaceuticals Limited, headquartered in Mumbai, India, is an integrated and research-based pharmaceutical company with a sharp focus on super specialty products. The company’s Oncology Division has emerged as a dedicated force in chemotherapeutic formulations, offering a diverse array of innovative solutions and therapies. Trusted globally by healthcare professionals and patients alike, Taj Pharma is renowned for its unwavering commitment to quality. Leadership and Vision Taj Pharmaceuticals Limited is not just a pharmaceutical company; it embodies sheer grit, a zeal to innovate, and a commitment to producing standout products. Dr. Ranvir Kumar Singh, Mr. Abhishek Singh, CEO Mrs. Priyanka Singh, the driving forces behind the company, envisioned a future where success wasn’t solely measured by numbers. This vision has propelled Taj Pharma to become one of […]
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Coronavirus in India: how the 2019-nCoV could impact the world’s second–most populated country Coronavirus-affected countries: Italy Middle East South Korea Japan Singapore Malaysia China USA UK Thailand Philippines Latest on India coronavirus (Covid-19) situation, followed by details on states, union territories and cities. For latest coronavirus news updates, jump to NCR, Punjab, Tamil Nadu, Haryana, Telangana, Rajasthan, Uttar Pradesh, Karnataka, Bihar, Ladakh, Jammu and Kashmir, Andhra Pradesh, Maharashtra, Odisha, Himachal Pradesh, Mizoram, Kerala.
![[Taj Pharma Mumbai] Supporting older people during the COVID-19 pandemic is everyone’s business](https://tajpharma.in/wp-content/uploads/cache/images/Taj-Pharma-India-Supporting-older-people-during-the-COVID-19-pandemic-is-everyone’s-business/Taj-Pharma-India-Supporting-older-people-during-the-COVID-19-pandemic-is-everyone’s-business-768913808.jpg)
![Immunotherapy comparable to chemo for some advanced stomach cancers [Taj Pharma Global Cancer initiative]](https://tajpharma.in/wp-content/uploads/cache/images/Immunotherapy-comparable-to-chemo-for-some-advanced-stomach-cancers-Taj-Pharma-Global-Cancer-initiative/Immunotherapy-comparable-to-chemo-for-some-advanced-stomach-cancers-Taj-Pharma-Global-Cancer-initiative-2308906734.jpg)
